Vaccinex (VCNX) SEC Filings & 10K Form $0.80 -0.08 (-9.23%) As of 06/11/2025 01:31 PM Eastern Add Compare Share Share SEC Filings Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Recent Vaccinex SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView04/15/20254:12 PMVaccinex (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 04/01/20256:01 AMVaccinex (Filer)Form NT 10-K03/27/20257:24 AMVaccinex (Filer)Form 15-12G03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT Get the Latest News and Ratings for VCNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vaccinex and its competitors with MarketBeat's FREE daily newsletter. 03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/20257:38 AMVaccinex (Filer)Form POS AM03/25/20257:40 AMVaccinex (Filer)Form POS AM03/25/20257:41 AMVaccinex (Filer)Form POS AM03/25/20257:43 AMVaccinex (Filer)Form POS AM03/25/20257:45 AMVaccinex (Filer)Form POS AM03/25/20257:46 AMVaccinex (Filer)Form POS AM03/25/20257:48 AMVaccinex (Filer)Form POS AM03/25/20257:50 AMVaccinex (Filer)Form POS AM03/25/20257:51 AMVaccinex (Filer)Form POS AM03/25/20257:24 AMVaccinex (Filer)Form S-8 POS03/25/20257:26 AMVaccinex (Filer)Form S-8 POS03/25/20257:28 AMVaccinex (Filer)Form POS AM03/25/20257:30 AMVaccinex (Filer)Form POS AM03/25/20257:31 AMVaccinex (Filer)Form POS AM03/25/20257:34 AMVaccinex (Filer)Form POS AM03/25/20257:35 AMVaccinex (Filer)Form POS AM03/25/20257:36 AMVaccinex (Filer)Form POS AM03/19/20253:15 PMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/07/20254:21 PMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 02/14/20253:43 PMARMISTICE CAPITAL, LLC (Filed by)Vaccinex (Subject)Form SCHEDULE 13G/A12/17/20248:32 AMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/18/20243:15 PMVaccinex (Subject)Zauderer Maurice (Filed by)Form SC 13D/A10/25/20243:11 PMVaccinex (Filer)Form 424B3Is Elon's empire crumbling? (Ad)The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd. Click here to see the Tesla shock that could blindside everyone.10/24/202411:15 PMVaccinex (Filer)Form EFFECT10/16/20243:44 PMVaccinex (Filer)Form S-3Registration statement under Securities Act of 1933 10/09/20243:37 PMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 09/27/20243:11 PMVaccinex (Filer)Form DNotice of Exempt Offering of Securities 09/20/20244:15 PMFCMI Parent Co. (Filed by)Vaccinex (Subject)Form SC 13D/A09/20/20243:57 PMVaccinex (Subject)Zauderer Maurice (Filed by)Form SC 13D/A09/19/20247:30 AMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/20/20245:04 AMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/14/20244:17 PMVaccinex (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 08/14/20247:35 AMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 07/31/20248:05 AMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 07/08/20243:16 PMVaccinex (Filer)Form 424B307/07/202411:15 PMVaccinex (Filer)Form EFFECT06/27/20243:41 PMVaccinex (Filer)Form S-3Registration statement under Securities Act of 1933 (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies Cardio Diagnostics SEC Filings PharmaCyte Biotech SEC Filings Turnstone Biologics SEC Filings Apollomics SEC Filings Mainz Biomed SEC Filings GT Biopharma SEC Filings Pasithea Therapeutics SEC Filings Omega Therapeutics SEC Filings Avalon GloboCare SEC Filings Chromocell Therapeutics SEC Filings SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:VCNX) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccinex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccinex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
